Pfizer Expands Cost-Cutting Measures, Reaffirms Outlook - WSJ
Pfizer Expands Cost-Cutting Measures, Reaffirms Outlook WSJPfizer Earnings Beat Isn’t Enough to Ease Stock Worries Barron'sPfizer leans on cost cuts to offset falling revenue ReutersPfizer expands cost cuts, tops quarterly profit estimates even as sales fall CNBCPfizer sticks to 2025 profit view as it shrugs off plunging Paxlovid sales with COVID infections in retreat MarketWatch
- Pfizer Expands Cost-Cutting Measures, Reaffirms Outlook WSJ
- Pfizer Earnings Beat Isn’t Enough to Ease Stock Worries Barron's
- Pfizer leans on cost cuts to offset falling revenue Reuters
- Pfizer expands cost cuts, tops quarterly profit estimates even as sales fall CNBC
- Pfizer sticks to 2025 profit view as it shrugs off plunging Paxlovid sales with COVID infections in retreat MarketWatch